AI and Autonomy Hong Kong researchers deploy AI to revolutionize lung cancer diagnosis Caretia’s platform can serve as an initial reader of CT scans, flagging nodules with diameters of at least 5 millimeters. Joseph Morton5 hours ago
Medical and Pharmaceutical Breath Diagnostics leaders promote their mission at Miami investment conference The National Investment Banking Association's event unites micro and small cap companies with potential investors Rowan DunneSeptember 21, 2025
Medical and Pharmaceutical Lung cancer detection dominates as breath biopsy gains clinical traction Clinicians, researchers, and healthcare systems increasingly rely on breath biopsy to detect chronic diseases early Joseph MortonSeptember 12, 2025
Mining Export fluctuations heighten conflict over global Rare Earth access Rare earth magnets stood out as a bright spot in China’s export performance Joseph MortonSeptember 8, 2025
Medical and Pharmaceutical Mercy BioAnalytics raises US$59M to commercialize ovarian cancer blood test The American Cancer Society was a significant funding contributor Rowan DunneSeptember 3, 2025
Medical and Pharmaceutical Penn State pioneers diabetes breath test that provides results in minutes New developments with breath analysis technology have made diagnosing several diseases easier than ever Rowan DunneAugust 25, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
Medical and Pharmaceutical QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics LEX Diagnostics develops molecular diagnostics to improve patient care by delivering clinical insights Joseph MortonJune 6, 2025
Medical and Pharmaceutical Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California The lawsuit exposes and brings closer scrutiny to “potentially anticompetitive” tactics by original equipment manufacturers Joseph MortonMay 21, 2025
Medical and Pharmaceutical Japanese startup ‘Craif’ raises US$22M to bring urine cancer biopsy to the U.S. Japan's venture capital firm X&KSK led the Series C round Rowan DunneApril 28, 2025